Natural Product: NPC159211

Natural Product IDNPC159211
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
LECIBJCWVOYLBA-VCRNMDDFSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 101048503
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LECIBJCWVOYLBA-VCRNMDDFSA-N
Standard InCHI InChI=1S/C52H92O2/c1-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29-46(53)54-45-34-36-50(7)43(48(45,4)5)33-37-52(9)44(50)31-30-42-47-41(40(2)3)32-35-49(47,6)38-39-51(42,52)8/h41-45,47H,2,10-39H2,1,3-9H3/t41-,42+,43-,44+,45-,47+,49+,50-,51+,52+/m0/s1
SMILES CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2CC[C@@H]2[C@H]4[C@@H](CC[C@]4(C)CC[C@@]32C)C(=C)C)C1(C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   748.71 Volume:   877.473
?
Van der Waals volume.
Dense:   0.853 LogP:   15.693
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   7.161
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -16.447
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   23.0 Rigid Bonds:   27.0
TPSA:   26.3
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   0.0 Rings:   5.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.063 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.944 Fsp3:   0.942
MCE-18:   91.802
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.942 Fluc inhibitor:   0.011
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.0
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.706 Promiscuous compounds:   0.255

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.152 MDCK Permeability:   -4.758
Pgp-inhibitor:   0.34 Pgp-substrate:   0.002
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.002
20% Bioavailability (F20%):   0.97 30% Bioavailability (F30%):   0.998
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.004 MRP1:   0.999
Plasma Protein Binding (PPB):   103.193% Volume Distribution (VD):   2.362
Fu: 0.174%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.998
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.971
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.969
CYP2C19-inhibitor:   0.998 CYP2C19-substrate:   0.831
CYP2C9-inhibitor:   0.505 CYP2C9-substrate:   0.143
CYP2D6-inhibitor:   0.008 CYP2D6-substrate:   0.51
CYP3A4-inhibitor:   0.99 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.534
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.014 Half-life (T1/2):  1.774

ADMET: Toxicity

hERG Blockers:  0.79 hERG Blockers (10um):  0.89
Human Hepatotoxicity (H-HT):  0.638 Drug-induced Liver Injury (DILI):  0.441
AMES Toxicity:  0.041 Rat Oral Acute Toxicity:  0.153
Maximum Recommended Daily Dose:  0.731 Skin Sensitization:  1.0
Carcinogencity:  0.809 Eye Corrosion:  0.727
Eye Irritation:  0.905 Respiratory Toxicity:  0.991
Drug-induced Neurotoxicity:  0.007 Ototoxicity:  0.284
Hematotoxicity:  0.328 Drug-induced Nephrotoxicity:  0.748
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.043
A549 Cytotoxicity:  0.966 Hek293 Cytotoxicity:  0.633
BCF:   0.248
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   6.386
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   7.775
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   8.289
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18758 Carapa grandiflora Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO17607 Jatropha grossidentata Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC159211 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9811 High Similarity NPC611062
0.8364 Intermediate Similarity NPC305835
0.8065 Intermediate Similarity NPC475416
0.7424 Intermediate Similarity NPC239362
0.7241 Intermediate Similarity NPC475509
0.6901 Remote Similarity NPC474092
0.6508 Remote Similarity NPC98270
0.6452 Remote Similarity NPC84868
0.6406 Remote Similarity NPC5280
0.6308 Remote Similarity NPC304194
0.6308 Remote Similarity NPC473742
0.6061 Remote Similarity NPC261616
0.5909 Remote Similarity NPC481227
0.5735 Remote Similarity NPC471901
0.5735 Remote Similarity NPC168231
0.5645 Remote Similarity NPC43300
0.5484 Remote Similarity NPC192638
0.5484 Remote Similarity NPC25511
0.5484 Remote Similarity NPC600137
0.5429 Remote Similarity NPC4309
0.5405 Remote Similarity NPC479062
0.5362 Remote Similarity NPC303863
0.5352 Remote Similarity NPC473690
0.5278 Remote Similarity NPC160506
0.5211 Remote Similarity NPC10005
0.5211 Remote Similarity NPC91525
0.5211 Remote Similarity NPC329943
0.5152 Remote Similarity NPC488509
0.5075 Remote Similarity NPC269396
0.5072 Remote Similarity NPC61107

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC159211 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5278 Remote Similarity NPD8035 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data